scispace - formally typeset
Y

Yanbao Xiong

Researcher at University of Maryland, Baltimore

Publications -  31
Citations -  867

Yanbao Xiong is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Signal transduction & Proinflammatory cytokine. The author has an hindex of 14, co-authored 27 publications receiving 662 citations.

Papers
More filters
Journal ArticleDOI

The Asp299Gly Polymorphism Alters TLR4 Signaling by Interfering with Recruitment of MyD88 and TRIF

TL;DR: The D299G polymorphism compromises recruitment of MyD88 and TRIF toTLR4 without affecting TLR4 expression, TLR 4–MD2 interaction, or LPS binding, suggesting that it interferes with TLR3 dimerization and assembly of intracellular docking platforms for adapter recruitment.
Journal ArticleDOI

Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20

TL;DR: Induction of endotoxin tolerance in vivo inhibits expression of proinflammatory mediators via impaired activation of IRAK4, p38, and NF‐κB and increases expression of negative regulators of TLR4 pathways.
Journal ArticleDOI

Endotoxin Tolerance Impairs IL-1 Receptor-Associated Kinase (IRAK) 4 and TGF-β-activated Kinase 1 Activation, K63-linked Polyubiquitination and Assembly of IRAK1, TNF Receptor-associated Factor 6, and IκB Kinase γ and Increases A20 Expression

TL;DR: Deficiencies in these signaling events in LPS-tolerant cells coincided with increased expression of A20, an essential deubiquitination enzyme, and sustained A20-IRAK1 associations, which are new determinants of endotoxin tolerance.
Journal ArticleDOI

R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

TL;DR: The R753Q polymorphism renders TLR2 signaling-incompetent by impairing its tyrosine phosphorylation, dimerization with TLR6, and recruitment of Mal and MyD88, and facilitates design of new therapeutic strategies.